Excess mortality seen for seniors with Alzheimer’s disease, dementia in COVID-19
Mar 08, 2022
Enrollees with Alzheimer’s disease and related dementias had increased adjusted mortality, especially for Asian, Black and Hispanic populations.
Prevalence of risk factors for Alzheimer’s, related dementias identified
May 20, 2022
The highest prevalence seen for high blood pressure and not meeting aerobic physical activity guidelines, followed by obesity.
Rapid olfactory decline may predict later cognitive impairment in seniors
Aug 04, 2022
Rapid olfactory decline also was associated with smaller gray matter volumes on MRI in the olfactory- and memory-associated brain regions.
One in three Alzheimer’s, dementia cases tied to modifiable risk factors
May 11, 2022
Risk factors differ based on sex and race and ethnicity.
Residential green space may aid cognition in adult women
Apr 28, 2022
Increasing green space is associated with higher scores for overall cognition and psychomotor speed/attention, but not higher scores for learning/working memory.
Risk for ischemic stroke up with antidopaminergic antiemetic use
Mar 29, 2022
The increase in risk is greatest for metopimazine and metoclopramide; the risk for ischemic stroke may be higher in first days of use.
Ethical considerations explored for aducanumab in Alzheimer’s disease
Nov 19, 2021
Grounds are insufficient to offer aducanumab (Aduhelm) for moderate, advanced Alzheimer’s dementia or for individuals without biomarker evidence of brain ß-amyloid, according to a position statement.
Early-onset Alzheimer’s disease patients in rural areas lack specialty care
Aug 09, 2022
Rural patients are more likely to receive a diagnosis and treatment from primary care providers.
Certain antihypertensive agents may aid cognition in elderly
Jun 21, 2021
Memory recall is better for up to three years with blood-brain barrier-crossing renin-angiotensin drugs versus nonpenetrant counterparts.
Interventions for Alzheimer’s disease improve cognition in men, women
May 03, 2022
Individualized multidomain interventions are equally effective for improving cognition in women and men.